Skip to content

Clinical trials

Multiple Myeloma trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: New Zealand Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20102
20112
20122
20132
20151
20161
20172
20191
20203
20212
20222
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting5
Recruiting3
Terminated2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Sanofi5
Celgene2
Hoffmann-La Roche2
Pfizer2
AbbVie1
Centocor, Inc.1
Genentech, Inc.1
Genmab1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma24
Recurrence4
Neoplasms3
Leukemia, Myeloid, Acute2
Blood Protein Disorders1
Bone Diseases1
Bone Marrow Diseases1
Bone Neoplasms1
Fractures, Bone1
Hematologic Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.